February 5, 2018 / 1:42 PM / 6 months ago

BRIEF-Novo Nordisk Launches Ozempic And Fiasp In The U.S.

Feb 5 (Reuters) - NOVO NORDISK:

* SAYS LAUNCHES OZEMPIC AND FIASP IN THE UNITED STATES

* BOTH DIABETES MEDICATIONS RECEIVED APPROVAL FROM THE U.S. FOOD AND DRUG ADMINISTRATION IN 2017 Further company coverage: (Copenhagen newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below